| 2025-04-01 | +0.61 % |
|
| 2025-03-28 | +0.09 % |
|
| 2025-03-27 | +1.09 % |
|
| 2025-03-14 | +0.29 % |
|
| 2025-03-12 | -2.15 % |
|
| 2025-03-10 | +1.76 % |
|
| 2025-03-07 | +1.71 % |
|
| 2025-03-04 | -0.85 % |
|
| 2025-03-03 | +0.86 % |
|
| 2025-02-28 | +1.96 % |
|
| 2025-02-27 | -0.79 % |
|
| 2025-02-21 | +0.04 % |
|
| 2025-02-20 | +0.82 % |
|
| 2025-02-18 | +0.83 % |
|
| 2025-02-13 | +2.44 % |
|
| 2025-02-11 | +0.83 % |
|
| 2025-02-10 | +2.13 % |
|
| 2025-02-06 | -2.07 % |
|
| 2025-02-05 | +0.63 % |
|
| 2025-02-04 | -0.34 % |
|
| 2025-02-03 | -0.59 % |
|
| 2025-01-31 | +3.97 % |
|
| 2025-01-30 | -6.7 % |
|
| 2025-01-29 | +0.16 % |
|
| 2025-01-28 | -0.95 % |
|
| 2025-01-27 | +4.11 % |
|
| 2025-01-23 | +2.06 % |
|
| 2025-01-21 | +1.62 % |
|
| 2025-01-17 | +1.07 % |
|
| 2025-01-16 | -1.27 % |
|
| 2025-01-15 | -0.16 % |
|
| 2025-01-14 | +0.91 % |
|
| 2025-01-10 | -0.12 % |
|
| 2025-01-07 | +0.1 % |
|
| 2025-01-06 | -0.37 % |
|
| 2025-01-03 | +2.26 % |
|
| 2024-12-31 | +0.36 % |
|
| 2024-12-30 | -1.28 % |
|
| 2024-12-27 | -1.02 % |
|
| 2024-12-24 | -0.56 % |
|
| 2024-12-23 | +1.7 % |
|
| 2024-12-19 | -2.69 % |
|
| 2024-12-17 | -2.81 % |
|
| 2024-12-13 | -0.39 % |
|
| 2024-12-12 | -3.76 % |
|
| 2024-12-10 | -2.44 % |
- Cigna (CI) stock declined by 2.44% as part of a broader downturn in the insurance sector, which has seen more than a 6% drop in response to renewed criticism of health insurers' business models following the tragic shooting of UnitedHealth Group's CEO, sparking negative sentiment towards the industry.
- Cigna (CI) stock fell by 2.44% last night, likely due to a combination of negative sentiment in the market and recent analyst downgrades or concerns related to its performance or outlook.
- Cigna (CI) stock, along with other health insurers, fell after the fatal shooting of UnitedHealthcare CEO Brian Thompson raised concerns about increased scrutiny and potential regulation of the health insurance industry, driven by public dissatisfaction with the healthcare system and its contribution to inflation.
- Cigna (CI) stock, along with other major health insurers, experienced a decline of -2.44% following the assassination of UnitedHealthcare CEO Brian Thompson, which triggered public outrage against the health insurance industry and led to a significant drop in stock prices across the sector. The decline can be attributed to the resulting negative sentiment and increased scrutiny directed at health insurers in the aftermath of the CEO's murder.
- The article discusses the recent arrest of Luigi Mangione for the murder of UnitedHealthcare CEO Brian Thompson, highlighting the public's chaotic reaction that reflects widespread frustration with health insurance systems, which has contributed to a broader narrative of hostility toward insurance companies, including Cigna (CI), resulting in a 2.44% decline in its stock value. Cigna's stock may have gone down due to increasing negative sentiment towards health insurance companies following this high-profile event, as it sheds light on longstanding grievances about industry practices, including the denial of claims and perceived corporate greed.
|
| 2024-12-09 | +0.42 % |
|
| 2024-12-06 | -1.49 % |
|
| 2024-12-05 | -2.27 % |
|
| 2024-12-04 | -1.43 % |
|
| 2024-12-03 | -0.64 % |
|
| 2024-12-02 | -0.22 % |
|
| 2024-11-29 | +0.39 % |
|
| 2024-11-26 | +0.6 % |
|
| 2024-11-25 | +1.39 % |
|
| 2024-11-22 | -0.49 % |
|
| 2024-11-21 | +2.07 % |
|
| 2024-11-20 | +0.28 % |
- Cigna (CI) stock rose by 0.28% likely due to the nomination of Dr. Mehmet Oz, who has significant investments in health insurance, including Cigna, as head of the Centers for Medicare & Medicaid Services, raising prospects of favorable policies that could benefit healthcare stocks.
- Cigna (CI) stock rose 0.28% last night, likely influenced by investor confidence and positive market trends, although the article primarily focuses on Public Service Enterprise Group (PEG) rather than Cigna.
- Cigna (CI) stock rose by 0.28% following the political appointment of Dr. Mehmet Oz, who, as the new overseer of the Centers for Medicare and Medicaid Services, supports policies that could expand the Medicare Advantage system, benefiting firms like Cigna.
|
| 2024-11-18 | +0.29 % |
|
| 2024-11-14 | -2.46 % |
|
| 2024-11-12 | -0.93 % |
|
| 2024-11-11 | +7.28 % |
|
| 2024-11-08 | +0.09 % |
|
| 2024-11-07 | +1.35 % |
|
| 2024-11-05 | +1.94 % |
|
| 2024-11-04 | -1.32 % |
|
| 2024-11-01 | +0.53 % |
|
| 2024-10-31 | +0.61 % |
|
| 2024-10-30 | +1.51 % |
|
| 2024-10-29 | -2.12 % |
|
| 2024-10-28 | -0.61 % |
|
| 2024-10-25 | -0.44 % |
|
| 2024-10-24 | +0.21 % |
|
| 2024-10-23 | +0.03 % |
|
| 2024-10-22 | -0.87 % |
- Cigna (CI) stock decreased by 0.87%, likely due to market fluctuations and investor sentiment influenced by recent financial reports and analyst ratings for related stocks in the sector.
- The Cigna (CI) stock fell by 0.87% due to broader market movements and investor reactions influenced by recent developments in the healthcare sector, particularly concerning competitors like Humana and market volatility surrounding related companies.
- Cigna (CI) stock fell by 0.87% after OLD National Bancorp IN disclosed a 19.9% reduction in its stake in the company, indicating a shift in investor confidence.
- Cigna (CI) stock declined by 0.87%, potentially due to a broader market trend following recent analyst downgrades and mixed earnings sentiments in the financial sector, as well as general market volatility impacting healthcare stocks.
- Cigna (CI) stock dipped by 0.87% following recent institutional investor activities, including capital increases, a sale by a company director, and mixed research analyst ratings, despite reporting strong quarterly earnings. The decline may be attributed to the stock's performance relative to investor expectations and insider selling, potentially signaling a lack of confidence among some stakeholders.
|
| 2024-10-21 | -4.69 % |
|
| 2024-10-18 | -4.85 % |
|
| 2024-10-17 | -1.52 % |
|
| 2024-10-16 | +2.79 % |
|
| 2024-10-15 | -0.74 % |
|
| 2024-10-14 | +0.33 % |
|
| 2024-10-11 | -0.06 % |
- The article discusses recent movements in institutional investments and analysts' ratings regarding Warner Bros. Discovery (WBD), while noting that Cigna (CI) stock was down by 0.06%. The decline in Cigna's stock price may not be directly addressed in the article but can be attributed to broader market trends or specific investor sentiment, as the article focuses primarily on WBD.
- The article discusses a recent decline of -0.06% in Cigna (CI) stock, attributed to changes in institutional investors' positions, including Park Avenue Securities LLC selling shares, which may reflect concerns or adjustments in market sentiment towards the company's stock.
- Cigna's stock (CI) declined by 0.06%, primarily due to ongoing challenges faced by retail pharmacies, including the impact of pharmacy benefit managers (PBMs) on reimbursement rates, which have contributed to numerous store closures and the growing issue of pharmacy deserts.
- Cigna (CI) stock declined by 0.06% as Perpetual Ltd significantly reduced its stake in the company by 85.8%, selling a large number of shares.
- Cigna (NYSE: CI) stock declined by 0.06% as Brendel Financial Advisors LLC significantly reduced its stake by 84% in the third quarter, indicating a potential decrease in investor confidence.
|
| 2024-10-10 | +1.09 % |
|
| 2024-10-09 | +0.81 % |
|
| 2024-10-07 | -0.42 % |
|
| 2024-10-04 | +0.33 % |
|
| 2024-10-03 | -0.04 % |
|
